FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

38618511000001108: Moxifloxacin 400mg tablets (Brown & Burk UK Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Jun 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1382991000001113 Moxifloxacin 400mg tablets (Brown & Burk UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1383001000001112 Moxifloxacin 400mg tablets (Brown & Burk UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Moxifloxacin 400mg tablets (Brown & Burk UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Moxifloxacin 400mg tablets (Brown & Burk UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Moxifloxacin 400mg tablets (Brown & Burk UK Ltd) Is a Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 400 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Moxifloxacin 400mg tablets (Brown & Burk UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Moxifloxacin 400mg tablets (Brown & Burk UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Moxifloxacin 400mg tablets (Brown & Burk UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Moxifloxacin 400mg tablets (Brown & Burk UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Moxifloxacin 400mg tablets (Brown & Burk UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Moxifloxacin true Inferred relationship Existential restriction modifier
Moxifloxacin 400mg tablets (Brown & Burk UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Moxifloxacin 400mg tablets (Brown & Burk UK Ltd) Has specific active ingredient Moxifloxacin hydrochloride true Inferred relationship Existential restriction modifier
Moxifloxacin 400mg tablets (Brown & Burk UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Moxifloxacin 400mg tablets (Brown & Burk UK Ltd) 5 tablet Has AMP True Moxifloxacin 400mg tablets (Brown & Burk UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start